Related Experiment Video
Updated: Aug 11, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Alterations of cell cycle-regulatory genes in prostate cancer
Pedro L Fernández1, Lluis Hernández, Xavier Farré
1Department of Anatomical Pathology, Hospital Clínic, University of Barcelona, Barcelona, Spain. plfernan@clinic.ub.es
Abstract:
Deregulated proliferation is one of the main events in neoplastic transformation, and this has prompted increased attention being given to the understanding of the mechanisms involved in cell cycle regulation and its alterations. The 'retinoblastoma pathway', a key effector controlling G1-S phase transition, includes several oncogenes and tumour suppressor genes which display a wide range of abnormalities with potential usefulness as markers of evolution or treatment response in prostate cancer. Among these, the existence of p53 mutations seems to predict resistance to radiotherapy or systemic treatment, and p16 overexpression or p27 downregulation seems to serve as markers of poor evolution. The well-established existence of a critical hormonal role in prostate carcinogenesis coupled with the relationship of androgenic activity and regulation of several cell cycle modulators forces cell cycle control in the prostate to be envisioned as a highly complex steroid-influenced system, which will undoubtedly have critical implications in the future management of prostate cancer patients.
Insights
Cell cycle regulation is crucial in prostate cancer, with alterations in the retinoblastoma pathway potentially serving as treatment response markers. Understanding these complex, steroid-influenced mechanisms is key for future patient management.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Deregulated cell proliferation is a hallmark of neoplastic transformation.
- The retinoblastoma pathway is a critical regulator of the G1-S phase transition.
- Prostate cancer involves complex alterations in cell cycle regulation.
Purpose of the Study:
- To explore the role of the retinoblastoma pathway in prostate cancer.
- To identify potential biomarkers for treatment response and disease evolution.
- To understand the influence of hormonal factors on prostate cancer cell cycle control.
Main Methods:
- Analysis of oncogenes and tumor suppressor genes within the retinoblastoma pathway.
- Investigation of p53 mutations, p16 overexpression, and p27 downregulation.
- Examination of the interplay between hormonal activity and cell cycle modulators.
Main Results:
- p53 mutations may indicate resistance to radiotherapy and systemic treatments.
- p16 overexpression and p27 downregulation are associated with poor prognosis.
- Prostate cancer cell cycle control is a complex, steroid-influenced system.
Conclusions:
- Alterations in the retinoblastoma pathway offer potential markers for prostate cancer evolution and treatment.
- Hormonal regulation significantly impacts cell cycle control in prostate cancer.
- These findings have critical implications for the future management of prostate cancer patients.
Related Concept Videos
Positive Regulator Molecules
Negative Regulator Molecules
Positive Regulator Molecules
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

